Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

Clinical trial NCT04722848 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04722848
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)ALL, Adult Philadelphia-Positive ALL

Start date: 2021-09-08
Primary completion: 2027-09-01
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.